Summary

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. Founded in 1916 as Commonwealth Serum Laboratories, CSL has grown to become the world's fifth largest biotechnology company with operations in over 35 countries. The company specializes in blood plasma derivatives, vaccines, antivenoms, and cell culture reagents used in medical and genetic research applications. CSL operates through several key divisions including CSL Behring (focusing on rare and serious diseases), CSL Seqirus (one of the world's largest influenza vaccine providers), CSL Plasma, and CSL Vifor. With over 32,000 employees globally, CSL maintains a strong R&D pipeline and has invested over US$3.3 billion in research and development over the past five years. The company is publicly traded on the Australian Securities Exchange and has its global headquarters in Parkville, Melbourne, Australia.

Job description

Responsibilities

Provide customer-centric insights based on global market research and analytical support to interpret key business and market dynamics to optimize growth of CSL Behring pipeline assets and business development opportunity assessment
Apply breadth and depth of experience in qualitative and quantitative market research methodologies, preferably across multiple countries
Partner with commercial development teams and other commercial functions to translate business questions into research objectives, recommend, develop and implement market research plans
Translate information and data from primary market research with patients and HCPs into actionable insights and recommendations, presenting work in an effective and easy-to-interpret manner to aid strategic and tactical decision making
Provide decision support for situation analyses, commercial assessments, product forecasting, brand planning, strategic planning, scenario analysis and other planning efforts
Keep abreast of new methodologies to ensure research is cost effective and provides optimal results
Manage external vendors and related budget ensuring timely delivery of quality insights to inform decision making
Experience in rare disease preferred

Qualifications

Bachelor degree in business, science or related field; Master's degree or MBA preferred
7+ years commercial experience including market research, analytics within biopharma (within consulting or industry)
Pharmaceutical or biotech experience required

Requirements

Bachelor degree in business, science or related field
Master's degree or MBA preferred
7+ years commercial experience including market research, analytics within biopharma (within consulting or industry)
Pharmaceutical or biotech experience required
Experience in rare disease preferred
Breadth and depth of experience in qualitative and quantitative market research methodologies, preferably across multiple countries

Company overview

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. Founded in 1916 as Commonwealth Serum Laboratories, CSL has grown to become the world's fifth largest biotechnology company with operations in over 35 countries. The company specializes in blood plasma derivatives, vaccines, antivenoms, and cell culture reagents used in medical and genetic research applications. CSL operates through several key divisions including CSL Behring (focusing on rare and serious diseases), CSL Seqirus (one of the world's largest influenza vaccine providers), CSL Plasma, and CSL Vifor. With over 32,000 employees globally, CSL maintains a strong R&D pipeline and has invested over US$3.3 billion in research and development over the past five years. The company is publicly traded on the Australian Securities Exchange and has its global headquarters in Parkville, Melbourne, Australia.